Dr. Eric Jonasch, MD
Claim this profileM D Anderson Cancer Center
Area of expertise
Renal Cell Carcinoma
Eric Jonasch, MD has run 10 trials for Renal Cell Carcinoma. Some of their research focus areas include:
Kidney Cancer
Eric Jonasch, MD has run 8 trials for Kidney Cancer. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
The University Of Texas M.D. Anderson Cancer Center
Clinical Trials Eric Jonasch, MD is currently running
177Lu Girentuximab + Cabozantinib + Nivolumab
for Advanced Renal Cell Carcinoma
To learn if giving 177Lu girentuximab in combination with cabozantinib plus nivolumab can help to control advanced clear cell renal cell carcinoma (ccRCC).
Recruiting
1 award
Phase 1 & 2
11 criteria
Data Collection
for VHL Syndrome
To collect information from patients with vHL disease. Information collected will include data on the status of the disease, any surgeries or therapies patients have received for vHL disease, and quality of life.
Recruiting
1 award
N/A
2 criteria
More about Eric Jonasch, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Eric Jonasch, MD has experience with
- Nivolumab
- Ipilimumab
- Nephrectomy
- Sunitinib
- 177Lu Girentuximab
- Cabozantinib
Breakdown of trials Eric Jonasch, MD has run
Renal Cell Carcinoma
Kidney Cancer
Retinal Vascularization
VHL syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Jonasch, MD specialize in?
Eric Jonasch, MD focuses on Renal Cell Carcinoma and Kidney Cancer. In particular, much of their work with Renal Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Eric Jonasch, MD currently recruiting for clinical trials?
Yes, Eric Jonasch, MD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Eric Jonasch, MD has studied deeply?
Yes, Eric Jonasch, MD has studied treatments such as Nivolumab, Ipilimumab, Nephrectomy.
What is the best way to schedule an appointment with Eric Jonasch, MD?
Apply for one of the trials that Eric Jonasch, MD is conducting.
What is the office address of Eric Jonasch, MD?
The office of Eric Jonasch, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.